Sara Michie

Sara Michie, MD, Professor, Department of Pathology, Stanford University School of Medicine

Research Description: Dr. Michie’s research program over the past 30 years has focused on defining the molecular mechanisms that control the migration of T cells from blood vessels into secondary lymphoid tissues and target tissues. She has focused on autoimmune diseases in humans and in mouse models of human autoimmune diseases, including type 1 diabetes mellitus (T1D). In addition, Dr. Michie is a board-certified anatomic pathologist with expertise in human and rodent histopathology and immunohistology.

Selected relevant publications (Stanford DRC members in BOLD):

  1. JaKa MM, Wood C, Veblen-Mortenson S, Moore SM, Matheson D, Stevens J, Atkins L, Michie S, Adegbite-Adeniyi C, Olayinka O, Po'e EK, Kelly AM, Nicastro H, Bangdiwala SI, Barkin SL, Pratt C, Robinson TN, Sherwood NE. Applying the Behavior Change Technique Taxonomy to Four Multicomponent Childhood Obesity Interventions. West J Nurs Res. 2020 Sep 10:193945920954782. doi: 10.1177/0193945920954782. PMID: 32909523. 

  2. Xu B, Iida Y, Glover KJ, Ge Y, Wang Y, Xuan H, Hu X, Tanaka H, Wang W, Fujimura N, Miyata M, Shoji T, Guo J, Zheng X, Gerritsen M, Kuo C, Michie SA, Dalman RL. Inhibition of VEGF (Vascular Endothelial Growth Factor)-A or its Receptor Activity Suppresses Experimental Aneurysm Progression in the Aortic Elastase Infusion Model. Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1652-1666. doi: 10.1161/ATVBAHA.119.312497. PMID: 31294623; PMCID: PMC6699755. 

  3. Shan Z, Wang W, Xu B, Xuan H, Ge Y, Wang Y, Wang L, Huang J, Fu W, Michie SA, Dalman RL. Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease. J Vasc Surg. 2018 Nov;68(5):1538-1550.e2. doi: 10.1016/j.jvs.2017.09.030. PMID: 29242064; PMCID: PMC5995616.